Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Lophine, the first chemiluminescent compound discovered in history, has rarely been applied for in vivo imaging since its discovery in 1877. In this report, we demonstrate that lophine's chemiluminescence emission could be significantly enhanced by caging the imidazole moiety via molecular afterglow mechanism. Notably, our study revealed a rare superoxide anion-mediated luminescence. Our novel probes JIMI-11 and JIMI-12 could be used for in vivo mouse imaging. Compared to its uncaged form JIMI-6, JIMI-11 exhibited a significant enhancement (126-fold) in vitro and a 190-fold higher emission signal in vivo. JIMI-11 selectively accumulates in white adipose tissues (WAT) and can be used to monitor changes in WAT mass in a mouse model of type-1 diabetes. Additionally, it can assess the therapeutic effects of Semaglutide in a mouse model of diet-induced obesity. Lastly, we designed JIMI-12 with a reactive oxygen/nitrogen species (ROS/RNS) responsive moiety as the caging group and demonstrated its utility for in vivo imaging of ROS in a lipopolysaccharide (LPS)-induced inflammatory mouse model. Our studies suggest that re-designing lophine-based probes could unlock their potential for both in vitro and in vivo applications. The ability to switch from chemiluminescence to molecular afterglow introduces a novel approach to designing imaging probes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/anie.202507174 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Three-Dimensional Afterglow Luminescence-MRI Fusion Tomography with Magnetically Targeted Luminescent-Magnetic Nanoparticles for Deep-Seated Tumor Imaging.
ACS Nano
September 2025
State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
Optical imaging offers high sensitivity and specificity for noninvasive cancer detection, but conventional techniques suffer from limited probe accumulation, tissue autofluorescence, and poor depth resolution. Afterglow luminescence overcomes autofluorescence by emitting persistent light after excitation, yet its utility in vivo remains hindered by weak tumor enrichment and two-dimensional readouts lacking spatial context. Here, we report luminescent-magnetic nanoparticles (LM-NPs) coencapsulating luminescent trianthracene (TA) molecules and iron oxide cores within the amphiphilic polymer pluronic-F127.
View Article and Find Full Text PDFRecent Advances in Cellulose-Derived Organic Afterglow Materials.
Macromol Rapid Commun
August 2025
State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai, P. R. China.
Cellulose-based organic afterglow materials have gained considerable interest due to their low toxicity, cost-effectiveness, and environmental benefits compared to traditional phosphors, with promising applications in anti-counterfeiting, bioimaging, and sensing. Although extensive research has been conducted on cellulose and organic afterglow materials, a comprehensive review systematically discussing the underlying mechanisms and applications of cellulose-based organic afterglow systems remains scarce. This review provides an in-depth analysis of the origin of long-lived afterglow emission in cellulose-based materials, highlighting the critical roles of intramolecular and intermolecular interactions, and proposes strategic design principles for optimizing performance.
View Article and Find Full Text PDFUltralong organic afterglow from small molecular host-guest materials: state of the art.
Light Sci Appl
August 2025
Frontiers Science Center for Flexible Electronics, Xi'an Institute of Flexible Electronics & Xi'an Institute of Biomedical Materials and Engineering, Northwestern Polytechnical University, Xi'an, 710072, China.
Ultralong organic afterglow materials are being actively explored as attractive candidates for a wide range of applications such as data storage, security inks, emergency lighting, etc., due to their unique long-lived excited state properties and inherent advantages of low cost, appreciable functionality and ease of preparation. In the last three years, much effort has been devoted to achieving efficient ultralong afterglow from organic small molecules, which possess controllable intermolecular interactions and defined energy levels, making them a good platform to suppress the non-radiative decays, hence stabilizing the excitons for efficient afterglow emissions at room temperature.
View Article and Find Full Text PDFOrganic photosensitizers: from molecular design to phototheranostics.
Chem Soc Rev
August 2025
State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), School of Flexible Electronics (Future Technologies), Nanjing Tech University, Nanjing 211816, China.
Photodynamic therapy (PDT) has emerged as a highly promising approach for tumor treatment, owing to its remarkable spatiotemporal precision and non-invasive characteristics. Nevertheless, the clinical translation of conventional organic photosensitizers remains constrained by inherent limitations, including a low photosensitization effect, limited reactive oxygen species (ROS) production in a hypoxic tumor microenvironment (TME), restricted tissue penetration depth, and inefficient tumor-targeting. To address these challenges, this review examines molecular engineering strategies through rational structure design, focusing on five critical aspects: (i) to promote the intersystem crossing (ISC) process by introducing heavy atoms, designing photosensitizers with a twisted conformation structure or polymerization for amplified ROS generation; (ii) to conquer tumor hypoxia construction of type I photosensitizers, fractional photosensitizers and other radical-generating photosensitizers; (iii) to excite with near-infrared light constructing a D-A structure, fabricating -aggregates, or utilizing two-photon excitation to improve the penetration depth; (iv) to target tumor tissues through conjugating photosensitizers with tumor-specific ligands or gene-encoded fragments to achieve tumor-targeted therapy; and (v) to reduce the off-target effect designing TME-activatable photosensitizers.
View Article and Find Full Text PDFMolecular Afterglow of Lophine-Based Luminophore and Its Imaging Applications.
Angew Chem Int Ed Engl
August 2025
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Boston, Massachusetts, 02129, USA.
Lophine, the first chemiluminescent compound discovered in history, has rarely been applied for in vivo imaging since its discovery in 1877. In this report, we demonstrate that lophine's chemiluminescence emission could be significantly enhanced by caging the imidazole moiety via molecular afterglow mechanism. Notably, our study revealed a rare superoxide anion-mediated luminescence.
View Article and Find Full Text PDF